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Background: This study sheds light on cell inactivating processes with focus on the phenomenon of cell-in-cell
(CIC). Cell-in-cell describes a cell process where one cell is being engulfed by another non-professional phagocyte.
We determined frequency and prognostic impact of CIC structures (CICs) as well as of senescent and apoptotic
cells in head and neck squamous cell carcinomas (HNSCC).
Methods: These different forms of cell inactivation as well as the proportion of proliferating and tumor cells were
assessed in 169 pre-radiochemotherapy biopsies and 32 post-therapy tumor resections by immunohistochemistry
of tissue microarrays. Four consecutive cancer sections were stained with antibodies specific for E-cadherin for CIC
detection, cleaved caspase-3 for apoptosis, H3K9Me for senescence and Ki67 as a proliferation marker. Positive
events were quantified in corresponding tumor areas.
Results: CICs were found in 55.5%, senescent cells in 67.1% and apoptotic cells in 93.3% of samples. While no
prognostic impact of apoptotic and senescent cells was observed, CICs turned out to significantly influence overall-
survival (p = 0.016) with a lack of CICs being prognostically beneficial. There was no correlation between CICs and
apoptosis and 98.9% of CICs were negative for cleaved caspase-3.
Conclusion: CIC formation is a frequent event in HNSCC and a superior predictive marker compared to senescence
and apoptosis. Independence of CIC and apoptosis and the adverse prognosis associated with numerous CICs lead
to the assumption that CICs might take up necrotic rather than apoptotic cells preventing an adequate antitumoral
immune response that would otherwise be initiated by necrotic cells through damage-associated molecular pattern
molecules.
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In multicellular organisms, precise control and coordin-
ation of cell proliferation, cell inactivation and cell death
are vital to maintain homeostasis of cells in tissues and
organs as slightest imbalances can lead to pathologies
like tumors and autoimmune diseases. For deeper under-
standing of these processes and their meaning we* Correspondence: luitpold.distel@uk-erlangen.de
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and apoptosis. Much attention has been focused on the
cell death mechanisms of apoptosis and necrosis and
their significance in tumors as well as healthy tissue.
However, the far less appreciated cell inactivating pro-
cesses of CIC and senescence may be equally essential.
To assess their role with regard to frequencies in tumor
specimens and clinical outcome we investigated a cohort
of HNSCC.
To best look into the subject of cell death stringent
definitions are vital. Kroemer et al. suggest that cell
death can be classified according to morphology,le is distributed under the terms of the Creative Commons Attribution 4.0
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logical characteristics [1]. The Nomenclature Committee
on Cell Death (NCCD) previously proposed three criteria
for the identification of a dead cell: (1) permanent loss of
the barrier function of the plasma membrane; (2) break-
down of cells into discrete fragments; or (3) engulfment of
cells by professional phagocytes or other cells endowed
with phagocytic activity [2].
According to the NCCD the phenomena of apoptosis
and necrosis can be further defined as follows: apoptosis
is characterized by cytoplasmic shrinkage, chromatin
condensation (marginalization), nuclear fragmentation
(karyorrhexis), so called blebbing and apoptotic bodies
and is considered a “regulated cell death”, generally re-
ferred to as “programmed cell death”. Necrosis presents
generalized swelling of the cytoplasm and organelles
(oncosis), alteration of chromatin (condensation) and
the nuclear membrane (dilatation) and is regarded as
“accidental cell death” [1]. Apart from these morpho-
logical features there was no reliable marker for detec-
tion of necrosis available.
Senescence defines the process of a cell going into an
irreversible cell-cycle arrest that is unresponsive to mito-
genic or oncogenic stimulation. However, senescent cells
are still viable and metabolically active without display-
ing the specific functions of their lineage [3]. The CIC
phenomenon describes a cell process where one cell is
being phagocytized completely by another non-
professional phagocytizing cell which has been observed
in a variety of malignancies. “Cell-in-cell” is an umbrella
term without further specification. Similar, yet different,
processes giving rise to cell-in-cell structures have been
introduced in literature: entosis, emperipolesis, cannibal-
ism and phagocytosis [4]. Entosis is the active invasion
of a living cell into another cell’s cytoplasm [5]. Emperi-
polesis defines the interaction of lymphocytes with other
cells and has been observed in physiological and patho-
physiological settings [6]. Cannibalistic tumor cells are
able to engulf other cells, including lymphocytes and
erythrocytes, either dead or alive, with the main purpose
to feed on them [7]. These mechanisms all have in
common that a living cell is taken up by another
non-professional phagocytizing cell and can be
broadly characterized as heterotypic or homotypic [8].
Although it is shown that an engulfed cell is able to
remain in the host cell, evade the host cell or under-
take cell division, phagocytosis most likely leads to
cell death of the incorporated cell and a subsequent
decomposition [9, 10]. Although the CIC phenomenon
has recently gained more and more attention, so far
exact details of its characteristics and mechanisms re-
main unclear. Preliminary findings originate several
questions: Which are role and condition of engulfing
and inner cell? Is the inner cell viable or dead? Iscell-in-cell a kind of cell death or rather a cell inter-
action process?
Our main focus in this study was to examine the for-
mation of CIC as a specific form of non-professional
phagocytosis. We assessed CIC’s prognostic meaning to
further examine its association with clinical pathogenesis
as well as its relation to apoptosis and senescence to
gain further knowledge about the identity of the inter-
acting cells. We quantified the frequencies of each of
these events in a HNSCC cohort pre- and post-
radiochemotherapy (RCT) and investigated their impact
on local failure-free-, metastasis-free- and overall-survival.
Materials and methods
Human specimens
Cancer tissue samples of 169 patients with HNSCC
were evaluated including 32 post-therapeutic biopsies
(Table 1). The post-therapy specimens were collected
after a minimum of 12 days, a maximum of 379 days
and an average of 46 days. The cohort consists of 29
female and 140 male patients with a median age of
56.4 years. All TNM stages are represented and
tumor localizations include oropharynx, floor of the
mouth and alveolar ridge. Patients were treated by
definite, adjuvant or neoadjuvant radiotherapy or ra-
diochemotherapy. Additional patients’ characteristics
are shown in Table 1 as well as characteristics for pa-
tients with post-therapeutic samples. All samples were
processed into tissue microarrays (TMAs) with cores
of 1.6–2 mm diameter (Fig. 1a-d). There were 2–4
available TMA cores per patient. Appendant clinical
data were extracted from the Erlangen Tumor Center
Database and from the patients’ records. Pretherapeu-
tic biopsies from the center of the tumor and the in-
vasive front as well as post-therapy tumor resections
were separately evaluated and compared. All patients
signed a “front door” informed consent allowing collection
of their tissue and clinical data. The study was approved
by the Ethics Review Committee of the University
Hospital Erlangen-Nürnberg, Erlangen, Germany.
Antibodies and immunohistochemistry
The following antibodies were used: anti-E-cadherin
(1:2000; clone 36/E-Cadherin; BD, Heidelberg, Germany)
to visualize membranes of cells to detect CIC structures
(Fig. 1a), anti-cleaved caspase-3 (1:200, polyclonal; Cell
Signaling, Danvers, MA, USA) to display apoptotic
cells (Fig. 1b), anti-H3K9Me (1:200; [BM1] Millipore,
Darmstadt, Germany) to detect senescent cells by
chromatin condensation (Fig. 1c) and anti-Ki67 (1:100,
clone MIB1; Dako Cytomation, Hamburg, Germany) to
highlight proliferating cells (Fig. 1d). Hematoxylin-eosin
staining was used for nuclear counter-staining. H3K9Me
was stained manually using a steam cooker and a
Table 1 Clinical characteristics of the head and neck squamous
cell carcinoma cohort
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Mean total dose 59.2 Grey
Mean dose per fraction 2.0 Grey
Chemotherapy
None 49 (29%)
5-FU + Cisplatin 93 (55%)
5-FU + Carboplatin 9 (5.3%)
Others 18 (10.7%)
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Base of the mouth 23 (71.9%)
Alveolar ridge 1 (3.1%)
Radiotherapy
Neoadjuvant 32 (100%)
Mean total dose 50.1 Grey
Mean dose per fraction 1.8 Grey
Chemotherapy
None 1 (3.1%)
5-FU + Cisplatin 29 (90.6%)
5-FU + Carboplatin 2 (6.3%)
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(TRS6, Dako Cytomation, Hamburg, Germany) for
antigen retrieval and an alkaline phosphatase-labeled
polymer kit (Zytochem-Plus AP-PolymerKit, Zytomed
Systems, Berlin, Germany) and Fast Red (Sigma-Aldrich,
Deisenhofen, Germany) for detection. The other stainings
were performed on a Ventana BenchMark ULTRA stainer
(Roche) using an UltraView DAB IHC Detection Kit
(Roche) for detection.
Imaging and image analysis
Stained TMAs were scanned with a high throughput
scanner (Mirax Scan, Zeiss, Göttingen, Germany). The
software Pannoramic Viewer (3D Histech, Budapest,
Hungary) was used for further processing of the scans.
Each TMA image was cut, exported and converted into
TIF files to be saved separately. Cell events were counted
in the same tumor area by precise alignment of each
stained TMA using the image processing software
Biomas (Erlangen, Germany). Each region of interest
was defined in the E-cadherin slide and transferred to
corresponding TMAs. Subsequently CICs, senescent
cells, apoptotic cells, proliferating cells as well as tumor
Fig. 1 Frequency of CIC structures, senescent and apoptotic cells assessed by immunohistochemistry. a E-Cadherin staining labelling numerous
CIC structures in HNSCC and magnifications of indicated region. (ai) Schematic drawing of a CIC structure illustrating defining criteria: complete
encirclement of the inner cell by the host cell membrane, circular shape of the inner cell and semilunar host cell nucleus. b Cleaved caspase-3
labeled HNSCC and magnifications of indicated region showing CIC structures negative for cleaved caspase-3. c H3K9ME labeled HNSCC showing
senescent cells and magnifications of indicated region. d Ki67 labeled HNSCC showing proliferating cells and magnifications of indicated region.
Comparative analysis of (e) CIC structures, (f) senescent cells, (g) apoptotic cells, (h) proliferating cells and (j) tumor cells in the center of the
tumor (pre- and post-RCT) and invasive front (pre-RCT). k Comparison of ratio of CIC structures, senescent cells and apoptotic cells in the center
of the tumor and invasive front compared to frequency of CIC structures in the center of the tumor pre-RCT as a reference
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automatically in each TMA by the use of the above-
mentioned image processing software.
Evaluation criteria
The following three criteria were defined for a coherent
evaluation of CICs: complete encirclement of the inner
cell by the host cell membrane, a round shape of the
inner cell and a semilunar host cell nucleus displaced to
the margin of the host cell (Fig. 1ai).
Statistical analysis
IBM SPSS Statistics version 19 (IBM Corp, Armonk, NY,
USA) was used for statistical analysis. Local failure-free
survival, metastasis-free-survival and overall survival
were determined according to Kaplan Meier. The log-
rank test was used to compare survival curves between
subgroups of patients. P-values below 0.05 were consid-
ered significant.Results
Frequency of cell events
Clinical characteristics of the study group are given in
Table 1. The HNSCC cohort consisted of 169 patients
with pre-RCT biopsies from all 169 patients and post-
RCT tissue samples from 32 patients. The median
follow-up was 4.5 years. Four consecutive cancer sec-
tions were stained with E-cadherin for CIC detection
(Fig. 1a), anti-cleaved caspase-3 for detection of apop-
tosis (Fig. 1b), anti-H3K9Me for detection of senescence
(Fig. 1c) and anti-Ki67 for identification of proliferating
cells (Fig. 1d). Apoptosis, senescence and proliferation
were assessed in positive cells morphologically consist-
ent with carcinoma cells, whereas other cells like stromal
or inflammatory cells were not included in the analysis.
We compared the frequency of CICs to senescent,
apoptotic, proliferating and tumor cells (Fig. 1e-j).
Center of the tumor pre-RCT (n = 169), invasive front
pre-RCT (n = 103) and center of the tumor post-RCT
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separately evaluated and compared with each other.
Significantly more CICs, senescent cells and apoptotic
cells were identified in samples from tumor centers
compared to invasive front samples (p = 0.003, p = 0.010,
p = 0.043) (Fig. 1e-g). Average numbers of all positive
events as well as the proportion of samples showing any
positive event in all respective markers decreased dis-
tinctly post-RCT. The highest number of proliferating
cells was found in the center of the tumor with distinct
decrease post-RCT (Fig. 1h). Additionally, tumor cells in
each TMA were counted (Fig. 1j).
Distribution and ratio of cell events
Subsequently the ratio of senescence, apoptosis and CIC
was determined in relation to CICs in the center of the
tumor as a reference (Fig. 1k). In the center of the tumor
of pre-RCT biopsies senescent cells constitute the major
fraction, whereas apoptotic events predominated in the
invasive front. Senescent cells were the most common
events post-RCT while apoptotic cells decrease. Figure 2a
depicts the overall distribution of each event. CICs were
found in 55.6% of the investigated cases (Fig. 2b), senes-
cent cells were detected in 67.1% of tissue samples
(Fig. 2c) and apoptotic cells in 93.3% (Fig. 2d). Numbers
of CIC structures varied from 0 to 86.7 cells mm−2, sen-
escent cells from 0 to 273.8 mm−2 and apoptotic cells
from 0 to 136 cells mm−2.
Taking all tissue samples into consideration, nearly
every biopsy showed apoptotic events while only about
half display CICs and senescent cells each. However
84.6% of tissues were positive for either CICs or senes-
cent cells. When looking at cases with events, absolute
numbers of cases with CICs and senescent cells were
comparably frequent as cases with apoptotic cells. The
overall mean of CICs was 8.2 CICs mm−2 and rising to
14.8 CICs mm−2 when considering only CIC-positive
samples (Fig. 2b). Accordingly, overall mean of senescent
cells was 12.6 mm−2 and increased to 18.8 mm−2 after
exclusion of negative cases (Fig. 2c). The mean value of
apoptotic cells was only slightly changed when consider-
ing positive cases only as apoptotic events were present
in the great majority of cases from the beginning
(Fig. 2d).
Correlation of cell events
To assess whether there is a relation between the fre-
quencies of CIC structures, senescence and apoptosis,
we performed correlation analysis of all three events.
The correlation between the three events was only weak
and did not reach statistical significance (Fig. 3a-c). We
further considered whether the internalized cells of
CICs are apoptotic cells. To answer this question we
investigated tumor areas in which CICs were found incorresponding regions in the cleaved caspase-3 staining.
In only 16 out of 1466 CIC structures apoptotic cells were
detected, indicating that 98.9% of CICs were negative for
cleaved caspase-3 and therefore apparently not involving
phagocytosis of apoptotic cells. Figure 1b illustrates an ex-
ample of a clearly detectable CIC structure negative for
cleaved caspase-3. We thereby presume that CIC forma-
tion is a phenomenon of non-apoptotic phagocytosis.
Prognostic relevance of CIC structures, senescence and
apoptosis
Survival rates were calculated according to Kaplan Meier
(Fig. 4a-d). CIC formation turned out to be a highly sig-
nificant predictor of overall-survival in pre-therapeutic
biopsies (p = 0.016), whereby a lack of CICs was
beneficial for the patients (Fig. 4b). CICs also have the
highest impact on failure-free survival (Additional file 1:
Figure S1a) and metastasis-free survival (Additional file 1:
Figure S1b) in pre-therapeutic biopsies of the central
tumor. Occurrence of senescent cells was associated with
a trend towards a prognostic advantage in pre-therapeutic
biopsies (Fig. 4b). The presence or absence of apoptotic
cells did not influence outcome pre-RCT (Fig. 4a, b). In
post-RCT biopsies, the prognostic significance of CICs
was lost compared to pre-RCT biopsies (Fig. 4c, d). How-
ever, apoptotic cells had a distinct impact on overall sur-
vival (p = 0.018) in post-RCT tissues (Fig. 4d) with no or
little apoptotic events being prognostically favorable.
Apoptotic cells also show prognostic significance regard-
ing local failure-free survival (p < 0.001) and no evidence
of disease (NED) (p < 0.001) post-RCT (Additional file 1:
Figure S1c). Kaplan Meier analysis of proliferating cells
and number of tumor cells are not depicted as they
showed no prognostic value.
Discussion
Our observations on frequency and prognostic impact of
CICs, senescence and apoptosis evoke pivotal questions
in view of previous findings and require further reflec-
tion. A remarking result is the fact that CICs and senes-
cence occur in a comparable frequency range as
apoptosis while not receiving equal consideration in lit-
erature. It is particularly noteworthy that CICs compared
to apoptotic cell death, inactivation by senescence and
proliferation is the only event with a prognostic rele-
vance pre-RCT. Necrotic death could not be evaluated
in this study due to the lack of a suitable immunohisto-
chemical necrosis marker.
Another interesting point is that the prognostic value
of CICs post-RCT was weaker than pre-RCT. Similarly,
apoptosis showed no prognostic value pre-RCT whereas
low apoptotic rates were associated with a favorable
prognosis post-RCT. RCT-driven selection processes
may lead to this change. The fraction of CIC-positive
Fig. 2 Frequency and distribution of CIC structures, senescent and apoptotic cells. a Overall frequency of CIC, senescent cells and apoptotic cells
in pre-therapeutic biopsies. Distribution of cell events arranged in order of frequency of (b) CIC, (c) senescence and (d) apoptosis. The percentage
of tissue samples having positive events, the overall mean (mean) and mean of tumor tissue with positive events only (mean+) is indicated
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Fig. 3 Correlation analysis. Correlation between (a) CIC and
senescence, (b) CIC and apoptosis and (c) apoptosis and senescence
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sues were CIC-positive prior to RCT. Median apoptotic
rates changed from 8.3 apoptotic cells per mm2 prior to
RCT to 1.1 apoptotic cells per mm2 post-RCT.
As only very few of the cells engulfed in CICs were
apoptotic and there was no significant correlation be-
tween CICs, apoptotic and senescent cells, the question
rises whether CICs are formed by phagocytized necrotic
cells. In our previous study 99.5% of CICs were negative
for cleaved caspase-3 going in line with the present find-
ing that apoptotic cells are very infrequently involved in
the formation of CICs. There was also no correlation be-
tween these events, indicating that high numbers of
apoptotic cells do not promote CIC formation [10].
Additionally we demonstrated in our previous studies
that phagocytosis by nonprofessional phagocytes includ-
ing primary fibroblasts, pancreatic adenocarcinoma, glio-
blastoma and head and neck cancer cells serves as a
mechanism to remove primary necrotic cells [11]. While
our data are consistent with a non-apoptotic cell-in-cell
process they do not rule out other scenarios previously
described in literature. For instance, Huang et al. identi-
fied four subtypes of CICs which could be formed
homotypically among tumor cells or heterotypically be-
tween tumor cells and leukocytes. They also stated that
macrophages could target live tumor cells to generate
CICs [12]. As mentioned above, entosis is described a
nonapoptotic cell death program in matrix-detached
cells initiated by the invasion of one living cell into an-
other [5]. Wang et al. report “emperitosis”, an apoptotic
cell-in-cell death process that occurs in heterotypic im-
mune killer cells expressing granzyme B inside tumor
cells which may serve as an in-cell danger sensation
model to prevent the killing of target cells from inside,
implying a unique mechanism for tumor cells to escape
from immune surveillance [13].
In our study, CICs turned out highly significant for
overall-survival whereby high CIC occurrences were as-
sociated with poor survival rates. Going in line with
other published data, this may support the possibility of
CIC formation stimulating tumor survival and progres-
sion by inducing aneuploidy and promoting nutrient
scavenging [5, 12]. Concomitantly, differing assumptions
on this issue have been provided and Huang et al. point
out that CIC profiles may vary from tumor to tumor
which may indicate different malignant stages and/or
inflammatory conditions [12, 14]. On the ground of
our previous findings we can support the proposition
that each tumor type may harbor its own unique CIC
pattern [10, 12].
Kepp et al. coined the term “immunogenic cell death”
where multiple stimuli can trigger cell death that does not
go unnoticed by the immune system [15]. Accordingly,
immunogenic cell death is accompanied by the production
Fig. 4 Kaplan-Meier analyses. Influence of CIC structures per mm2, senescent cells per mm2 and apoptotic cells per mm2 in the center of the
tumor of pre-therapeutic biopsies on NED (a) and overall survival (b). Influence of CIC structures per mm2, senescent cells per mm2 and apoptotic
cells per mm2 in the center of the tumor of post-therapeutic biopsies on NED (c) and overall survival (d). The median served as a cut off to separate
group in all analyses. Blue solid lines indicate cases below the median and green spotted lines with counts over the median
Schenker et al. Radiation Oncology  (2017) 12:21 Page 8 of 9of a series of immunostimulatory damage-associated mo-
lecular patterns (DAMPs), i.e. molecules that are released
or exposed during cytoprotective stress responses or upon
cell death [15]. Emission of DAMPs promotes the recruit-
ment of antigen presenting cells to sites of ongoing im-
munogenic cell death and assists to their ability to take up
dead cell-derived particulate material, as well as their
capacity to prime an adaptive immune response [15]. As-
suming that CICs engulf necrotic cells which would undernormal circumstances release DAMPs, an immunologic
reaction to the tumor could thereby be inhibited.
Accordingly, occurrence of CICs as an adverse prognosti-
cator by attenuating anti-tumoral immune responses
would be coherent.
The versatile and partly antithetic observations made
on CICs convey that CIC represents a highly complex
form of intercellular interaction. Conceivably, various
forms of CICs coexist affecting tissues and tumor
Schenker et al. Radiation Oncology  (2017) 12:21 Page 9 of 9progression in different ways. Elucidation of the mecha-
nisms underlying these observations is essential to fur-
ther examine the significance of cell-in-cell in healthy
tissue and pathological processes.
Conclusion
Our immunohistochemical analysis shows that CICs and
senescence, taken together, occur with similar frequency
in head and neck squamous cell carcinomas as apop-
tosis. We demonstrated that CICs have a significant
impact on clinical outcome pre-RCT as opposed to sen-
escent and apoptotic cells. We speculate that CICs im-
pair the production of DAMPs by taking up necrotic
cells inhibiting an adequate anti-tumoral immune re-
sponse which is reflected by the adverse prognosis of pa-
tients with high CIC occurrences. CIC frequency might
therefore be a valuable independent prognostic factor
which could be taken into consideration for diagnostics
and treatment strategies.
Additional file
Additional file 1: Figure S1. Kaplan-Meier analyses. Influence of CIC
structures per mm2, senescent cells per mm2 and apoptotic cells per
mm2 in the center of the tumor of pre-therapeutic biopsies on local
failure-free survival (a) and metastasis-free survival (b). Influence of
apoptotic cells per mm2 in the center of the tumor of post-therapeutic
biopsies on NED (c). (PNG 437 kb)
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